FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/12/2023
Back to search
Official data from USPTO
THE PHARM BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
11/12/2023
Trademark type
Combined
Nice classes
36, 44, 45
Filing date
09/10/2021
Registration date
07/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/04/2023
Last transaction
07/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Parkville VIC 3052, AU
Examiner
JARAMILLO, JAVIER R
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an incomplete hexagon above and intersecting another incomplete hexagon. A short, rounded line segment extends downward from the lowest vertex of the lower hexagon. To the right of this design appears the wording "THE PHARM BIO" in stylized font.
Holders and representatives
Holders
The Pharm Bio Pty Ltd as trustee for The
The Pharm Bio Pty Ltd as trustee for ThePharm Bio Unit Trust
SYNthesis Research Pty Ltd
Representatives
Neil B Friedman Hodgson Russ LLP
Technical classification
Nice Classes
Class 36Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Financial servicescapital investment; funds managementmanagement of a capital investment fund; venture capital financing; venture capital fund management; investment servicesasset acquisition for financial investment; investment of funds for others; commercial property investment servicesinvestment of funds for others in the field of commercial property; capital investment in real estate; trustee servicesinvestment trusteeship; trust investment servicesinvestment and trust company services; investment management; financial investment custody servicesmaintaining possession of financial assets for others for financial management purposes; financial portfolio management; financial investment fund servicesinvestment of funds for others; trading in stocks; advancement of fundscash advance services for businesses and merchants; capital investment; financial servicescommodity trading for others; financial servicesinvestment asset management; financial servicesfinancial portfolio management; project financing; financing services; financial advisory services; financial consultancy; financial information services; investment advice; financial analysisinvestment analysis; providing investment information; financial researchinvestment research; provision and funding of educational scholarships; advisory and consultancy services relating to the aforementioned services
Class 44
Medical advisory services relating to pharmaceutical products; pharmaceutical advisory services; provision of medical information relating to pharmaceuticals; consultancy and advisory services in relation to medical services; consultancy relating to health care; health care consultancy servicesconsultancy services in the field of medical care
Class 45
Licensing of intellectual property rights; legal services related to the exploitation of intellectual property rights; enforcement of intellectual property rights by means of submitting copyright takedown notices for others; advisory services relating to intellectual property rights; legal research relating to intellectual property
Publications
History of USPTO decisions and trademark events.
38 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/05/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
10/05/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2023
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
05/30/2023
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
05/26/2023
GPNX
NOTIFICATION PROCESSED BY IB
04/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2023
PUBO
PUBLISHED FOR OPPOSITION
04/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/22/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/08/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/08/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/08/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/08/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/23/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/23/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/23/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/27/2023
RFNP
REFUSAL PROCESSED BY IB
08/23/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/15/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/29/2022
RFRR
REFUSAL PROCESSED BY MPU
07/28/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/07/2022
CNRT
NON-FINAL ACTION WRITTEN
07/06/2022
DOCK
ASSIGNED TO EXAMINER
06/15/2022
MAFR
APPLICATION FILING RECEIPT MAILED
04/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/29/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/14/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/03/2022
Continuous trademark protection
Get notified about every new filing that threatens THE PHARM BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.